Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT.

Literature DB >> 22814296

IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT.

M M Pfeiffer, M Schumm, Ingo Müller, R Handgretinger, P Lang.

Abstract

Entities: Gene Species

Mesh：

Substances：

Year: 2012 PMID： 22814296 DOI： 10.1038/leu.2012.167

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing's sarcoma patients.

Authors: P Schlegel; T Feuchtinger; C Nitschke-Gérard; U J Eva Seidel; A-M Lang; C Kyzirakos; H-M Teltschik; M Ebinger; M Schumm; E Koscielniak; R Handgretinger; P Lang
Journal: Bone Marrow Transplant Date: 2015-06 Impact factor: 5.483

Review 2. Clinical grade purification and expansion of natural killer cells.

Authors: Natalia Lapteva; Susann M Szmania; Frits van Rhee; Cliona M Rooney
Journal: Crit Rev Oncog Date: 2014

3. Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model.

Authors: Michelle Escobedo-Cousin; Nicola Jackson; Raquel Laza-Briviesca; Linda Ariza-McNaughton; Martha Luevano; Sophie Derniame; Sergio Querol; Michael Blundell; Adrian Thrasher; Bernat Soria; Nichola Cooper; Dominique Bonnet; Alejandro Madrigal; Aurore Saudemont
Journal: PLoS One Date: 2015-10-14 Impact factor: 3.240

IL-15-stimulated CD3/CD19-depleted stem-cell boosts in relapsed pediatric patients after haploidentical SCT.

1. Favorable NK cell activity after haploidentical hematopoietic stem cell transplantation in stage IV relapsed Ewing's sarcoma patients.

Review 2. Clinical grade purification and expansion of natural killer cells.

3. Natural Killer Cells Improve Hematopoietic Stem Cell Engraftment by Increasing Stem Cell Clonogenicity In Vitro and in a Humanized Mouse Model.

Review 4. Tumor-related interleukins: old validated targets for new anti-cancer drug development.

5. NK Cells as Possible Prognostic Factor in Childhood Acute Lymphoblastic Leukemia.

6. NKG2D Signaling Leads to NK Cell Mediated Lysis of Childhood AML.

Review 7. The Role of Natural Killer Cells as a Platform for Immunotherapy in Pediatric Cancers.